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Abstract
Different lifestyle patterns across Europe may influence plasma concentrations of B-vitamins and one-carbon metabolites and their relation
to chronic disease. Comparison of published data on one-carbon metabolites in Western European regions is difficult due to differences in
sampling procedures and analytical methods between studies. The present study aimed, to compare plasma concentrations of one-carbon
metabolites in Western European regions with one laboratory performing all biochemical analyses. We performed the present study in the
European Prospective Investigation into Cancer and Nutrition (EPIC) cohort among 5446 presumptively healthy individuals. Quantile
regression was used to compare sex-specific median concentrations between Northern (Denmark and Sweden), Central (France, Germany,
The Netherlands and United Kingdom) and Southern (Greece, Spain and Italy) European regions. The lowest folate concentrations were
observed in Northern Europe (men, 10·4 nmol/l; women, 10·7 nmol/l) and highest concentrations in Central Europe. Cobalamin
concentrations were slightly higher in Northern Europe (men, 330 pmol/l; women, 352 pmol/l) compared with Central and Southern
Europe, but did not show a clear north–south gradient. Vitamin B2 concentrations were highest in Northern Europe (men, 22·2 nmol/l;
women, 26·0 nmol/l) and decreased towards Southern Europe (Ptrend , 0·001). Vitamin B6 concentrations were highest in Central
Europe in men (77·3 nmol/l) and highest in the North among women (70·4 nmol/l), with decreasing concentrations towards Southern
Europe in women (Ptrend , 0·001). In men, concentrations of serine, glycine and sarcosine increased from the north to south.
In women, sarcosine increased from Northern to Southern Europe. These findings may provide relevant information for the study of
regional differences of chronic disease incidence in association with lifestyle.
Key words: B-vitamins: Amino acids: One-carbon metabolism: Europe
One-carbon metabolism involves transfer of one-carbon units
from the amino acids serine or glycine to tetrahydrofolate to
form methylenetetrahydrofolate. Methylenetetrahydrofolate is
either used for the synthesis of thymidine and purines,
which are building blocks for DNA, or it is reduced to methyl-
tetrahydrofolate, which re-methylates homocysteine to meth-
ionine. Methionine is activated to S-adenosylmethionine, the
major methyl group donor for the methylation reactions of
many substrates. The vitamins B2, B6 and B12 function as
cofactors for enzymes, catalysing the conversion of homocys-
teine to methionine or cystathionine and cysteine. Choline is
another source of one-carbon units. It is converted to betaine,
which in the liver and kidneys serves as a substrate in another
reaction re-methylating homocysteine to methionine, with
dimethylglycine as a product. Sarcosine is formed from
dimethylglycine or during the metabolism of excess methion-
ine, and can be further metabolised to glycine, which is an
important source of serine(1).
B-vitamins, related amino acids and variants of genes
coding for enzymes involved in one-carbon metabolism may
influence cellular growth, differentiation and function, which
provides plausible biological background that links one-
carbon metabolism to various disease outcomes. Although
results from observational and experimental studies have not
always been consistent, the majority of studies suggest that
B-vitamins and other components related to one-carbon
metabolism are associated with neural tube defects(2), the
metabolic syndrome(3,4), CVD(5), cognitive impairment(6),
bone health(7) and different types of cancer(8,9).
The methylenetetrahydrofolate reductase (MTHFR)
677C! T polymorphism(10) and lifestyle factors such as
smoking(11) and alcohol consumption(12,13) may affect blood
concentrations of B-vitamins and other components of one-
carbon metabolism(14). There is a great diversity in dietary
and lifestyle patterns among European countries(15–17),
which are likely to influence plasma status of nutrients and
the subsequent risk of morbidity and mortality(18). For
example, a Mediterranean diet – rich in plant foods and
folate – in combination with healthy lifestyle factors such as
abstaining from smoking, moderate alcohol consumption
and being physically active, has been associated with a
lower mortality rate(19).
The European Prospective Investigation into Cancer and
Nutrition (EPIC) and a number of multicentre studies have
been conducted to investigate dietary intake or blood concen-
trations of B-vitamins as determinants of health in Europe.
These studies show relatively low intake of B-vitamins in
Scandinavian countries, the Netherlands, Germany and
Greece(20,21). However, no major differences in B-vitamin
intake across EPIC study centres have been observed(22,23).
The SENECA (Survey in Europe on Nutrition and the Elderly,
a Concerted Action) study showed large differences in plasma
vitamin status between study centres, with vitamin B6 concen-
trations being lowest in Greece and Denmark(24), but no clear
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geographical patterns were observed(25). A summary of thirty-
one European studies on plasma/serum B-vitamins revealed
relatively low folate concentrations in Norway and Sweden,
while lower vitamin B12 concentrations were observed in the
Netherlands, Germany, Czech Republic and Italy compared
to other countries(21).
Data on plasma concentrations of components related to
one-carbon metabolism in European countries are inconclu-
sive. Comparison of plasma concentrations between individ-
ual European studies is difficult due to different blood
sampling protocols and large inter-assay variability by labora-
tory methods used in different studies(26). The present study
aimed to investigate patterns in plasma B-vitamin status,
amino acids and related methylamines in Western European
regions, while eliminating variability in sampling procedures
and assay methods, as all biochemical analyses were carried
out in citrate plasma by a single laboratory. With data on
5446 individuals from the EPIC cohort, this is the largest popu-
lation to date to compare patterns across European regions
and in a population with no mandatory fortification with
folic acid or other B-vitamins.
Methods
Study population
The EPIC study investigates associations between diet, lifestyle
and cancer risk(27) among individuals recruited between 1992
and 2000 living in ten European countries. The present cross-
sectional study comprises the control individuals who were
matched to cancer cases participating in four nested case–
control sub-studies on gastric- (GC, n 805), colorectal- (CRC,
n 2408), lung- (LC, n 1778) and pancreatic cancer (PC,
n 455). Matching criteria were sex, age group (^2·5 years),
study centre and date of blood collection (all studies), and
additionally for time of blood collection and fasting status in
the PC study. Blood samples from EPIC-Oxford and
EPIC-Norway centres were exposed to ambient temperatures
for up to 48 h. As some B-vitamins and related metabolites
are unstable under such conditions(26,28), all EPIC-Oxford
(n 221) and EPIC-Norway (n 11) samples were excluded
from the present analyses. Participants in the present study
were from Greece (n 288, recruited from studies on GC
(n 32), CRC (n 51), LC (n 182) and PC (n 23), Spain (n 638,
recruited from studies on GC (n 107), CRC (n 238), LC
(n 254) and PC (n 39)), Italy (n 799, recruited from studies
on GC (n 186), CRC (n 294), LC (n 277) and PC (n 42)),
France (n 133, recruited from studies on GC (n 10), CRC
(n 60), LC (n 48) and PC (n 15)), Germany (n 797 recruited
from studies on GC (n 117), CRC (n 313), LC (n 312) and
PC (n 55)), The Netherlands (n 650, recruited from studies
on GC (n 78), CRC (n 297), LC (n 237) and PC (n 38)),
United Kingdom (n 919, recruited from studies on GC
(n 104), CRC (n 421), LC (n 350) and PC (n 44)), Denmark
(n 500, recruited from studies on GC (n 43), CRC (n 373),
LC (n 0) and PC (n 84)) and Sweden (n 722, recruited from
studies on GC (n 128), CRC (n 361), LC (n 118) and PC
(n 115)). The present study was conducted according to the
guidelines laid down in the Declaration of Helsinki, and all
procedures involving human subjects were approved by the
ethical review boards from the International Agency for
Research on Cancer; all local participating centres approved
the study. Written informed consent was obtained from all
the subjects.
Data collection
Blood sampling and laboratory analyses. In each of the
recruitment centres, fasting (42·8 % (6·6 % in North, 30·7 % in
Central and 5·5 % in Southern Europe)) or non-fasting
(47·2 % (6·8 % in North, 14·3 % in Central and 26·1 % in
Southern Europe)) blood samples of at least 30 ml were
drawn at baseline between March 1991 and April 1999. In
9·9 % (9·1 % in North, 0·7 % in Central and 0·1 % in Southern
Europe) information on prandial status was missing. Samples
were stored at 5–108C, protected from light and transported
to local laboratories for processing and aliquoting as pre-
viously described(27,29). In all countries, except Denmark and
Sweden, blood was separated into 0·5 ml aliquots (serum,
plasma, erythrocytes and buffy coat for DNA extraction) and
stored into plastic CBS strawse, which were heat sealed
and stored in liquid N2 (21968C). Half of the aliquots were
stored at the local study centre and the other half in the central
EPIC biorepository at the International Agency for Research
on Cancer (Lyon, France). In Denmark, aliquots of 1·0 ml
were stored locally at 21508C under N2 vapour. In Sweden,
samples were stored at 2808C.
For the present study, blood samples collected into citrate
plasma tubes were used for biochemical analyses in the lab-
oratory of Bevital AS (http://www.bevital.no). The present
study included B-vitamins (folate, vitamins B2 and B6 species,
vitamin B12 and its marker methylmalonic acid (MMA)), meth-
ylamines (choline, betaine and dimethylglycine) and amino
acids (total homocysteine (tHcy), methionine, total cysteine,
cystathionine, serine, glycine and sarcosine). Vitamin B2
measures included plasma concentrations of riboflavin and
FMN; pyridoxal-50-phosphate, pyridoxal (PL) and 4-pyridoxic
acid were measures of vitamin B6 status. Vitamin B2 and B6
species and methylamines were determined by LC–MS/
MS(30–33), and MMA and amino acids by GC–MS/MS based
on methylchloroformate derivatisation(33,34). Vitamin B12 was
determined with a Lactobacillus leichmannii microbiological
method(35) and plasma folate with a Lactobacillus casei micro-
biological method, both adapted to a microtitre plate format,
and analysis was carried out on a robotic workstation
(Micro-lab AT plus 2; Hamilton Bonaduz AG)(36). Within-
and between-day CV for folate were 3–20 %(36), 3–20 % for
vitamin B2 vitamers
(32), 6–22% for vitamin B6 vitamers
(32), , 5%
for vitamin B12, tHcy and MMA
(34,35),, 5% for choline, betaine
and dimethylglycine(31) and ,5% for the remaining amino
acids(33,34).
FMN was not measured in the LC study; serine, glycine and
sarcosine were not measured in gastric- and colorectal studies;
and the methylamines were not measured in LC and PC studies.
The MTHFR 677C! T polymorphism (rs 1801133) was
determined by matrix-assisted laser desorption/ionisation
B-vitamins and one-carbon metabolites in Europe 365
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time-of-flight MS(37,38) in the studies on GC, CRC and LC. Data
on the MTHFR 677C! T polymorphism were available for
87·8 % of the participants (664 missing).
Descriptive variables. Data on age, sex and information
on lifestyle factors known to affect B-vitamin status, such as
smoking status(11) (never, former, current, missing) and alco-
hol consumption, were collected at enrolment in the study.
Total alcohol consumption (pure ethanol in g/d) at baseline,
which represented consumption over the 12 months before
enrolment in the EPIC cohort, was determined from lifestyle
questionnaires. The present study distinguishes between
abstainers, very light or occasional consumers (0·1– , 4·9 g/d),
moderate consumers (4·9– , 30 g/d) and heavy consumers
($30 g/d). Data on total alcohol intake were available for
99·6 % of the participants (twenty-two missing).
Statistical methods
Statistical analyses were conducted for the total study popu-
lation, as well as within each European region (North:
Sweden and Denmark; Central: France, United Kingdom, the
Netherlands and Germany; South: Italy, Spain and Greece)
and country. Using the PROC CORR SAS procedure, we calcu-
lated Spearman rank correlation coefficients between
metabolites, adjusting (using a PARTIAL statement) for age,
sex, sub-study and prandial status. Because riboflavin may
be formed from FMN(39), we considered the sum of riboflavin
and FMN as a measure for vitamin B2 status. As PL may be
formed from pyridoxal-50-phosphate in blood and 4-pyridoxic
acid from PL in the liver(40), we considered the sum of pyri-
doxal-50-phosphate, PL and 4-pyridoxic acid to be a measure
of vitamin B6 status. Some metabolites were not normally
distributed. Therefore, differences in crude concentrations of
the B-vitamins between demographic and lifestyle groups
were assessed by non-parametric tests, Mann–Whitney
U tests or x 2 tests where appropriate.
Because blood concentrations of several metabolites varied
according to sub-studies as well as age groups, medians of
one-carbon-related nutrients across European regions were
described and estimated by using a direct standardisation
method(41). First, the total population was considered as ‘a
standard’ and was distributed into all possible combinations
of three age groups (#60, 60– # 70 and .70 years), four
sub-studies (GC, CRC, PC and LC) and three groups of pran-
dial status (fasting, non-fasting and missing information on
prandial status), which comprises thirty-six subgroups
altogether. For each combination, we estimated the relative
frequency or weight (w) from the total population. Second,
the median (m) of each metabolite was estimated for each
combination of sub-study and age in each region by using
quantile regression models. Finally, the standardised median
of each metabolite within each region was defined as the
weighted average of the respective median m, weighted
by w. This procedure was also used for calculating the 5th
and the 95th percentiles of the metabolites. Tests for trends
in plasma concentrations of the one-carbon metabolites
across the European regions were assessed by median
regression (i.e. quantile regression), in which we regressed
crude blood concentrations of the metabolites against the
European region, adjusted for age groups, sub-studies and
prandial status. P for difference between regions was assessed
by the Wald test.
We further investigated proportional differences in metab-
olite concentrations across the three European regions at the
0·025, 0·05, 0·25, 0·50, 0·75, 0·95 and 0·975 quantiles of the
outcome variables(42). The results were plotted graphically,
displaying the percentage differences between the European
regions (with Southern Europe as the reference) v. the metab-
olite concentrations at each quantile cut-off. These models are
adjusted for age, sex, sub-study and prandial status. In
addition, we investigated whether relations of plasma folate
and tHcy with the MTHFR 677C! T polymorphism differed
across regions by plotting proportional differences across
MTHFR genotypes against metabolite concentrations at each
quantile cut-off of the outcome for each region separately.
Statistical analyses were performed using SAS version 9.2 for
Windows (SAS Institute, Inc.) and the open-source statistical
program environment R with the package ‘quantreg’ to
obtain quantile regression results(43).
Results
Characteristics of the study population and data integrity
The average age of the total study population (n 5446) was 59·0
years, and 46·1 % were women. The UK study population
had the highest mean age (65·4 years) and the Spanish
study population had the lowest (54·2 years). The French
study population only included women and the German study
population represented the largest proportion of men (76·7 %)
(data not shown). The proportion of current smokers was
lowest in the Central European countries (16·4 %), and the pro-
portion of individuals consuming $30 g alcohol/d was highest
in the Southern European countries (22·2 %) (Table 1).
The prevalence of the MTHFR 677TT genotype was 17·9 %
in Southern Europe compared with 12·2 % in Central Europe
and 8·2 % in Northern Europe (Table 1).
Spearman correlation coefficients (rs), adjusted for age, sex,
sub-study and prandial status between the vitamin B6 species,
ranged from 0·61 to 0·71, riboflavin correlated with FMN
(rs ¼ 0·26), vitamin B12 with MMA (rs ¼ 20·26) and tHcy
(rs ¼ 20·24) and folate with tHcy (rs ¼ 20·30, all P values
,0·01). These correlations were essentially similar across the
European regions and individual countries (data not shown).
Table 2 shows concentrations of B-vitamins and tHcy
according to relevant demographic and lifestyle factors.
Women had higher concentrations of vitamins B2 and B12
compared with men, whereas vitamin B6 and tHcy were
higher in men. Furthermore, concentrations of vitamin B2,
folate and tHcy were higher, whereas vitamin B12 was lower,
in individuals older than 60 years compared with younger par-
ticipants. Concentrations of all vitamins were lower among
smokers compared with ex- and never smokers, whereas
tHcy was lowest in never smokers. Those consuming $30 g
alcohol/d had lower vitamin B2, B12 and folate concentrations,
but higher vitamin B6 and tHcy concentrations, compared with
S. J. P. M. Eussen et al.366
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abstainers and very light or occasional consumers of alcohol.
Furthermore, plasma folate concentrations were lower
among those with the MTHFR 677TT genotype compared
with the CC and CT genotypes, whereas tHcy concentrations
were higher in the MTHFR 677TT genotype. Concentrations
of B-vitamins according to these demographic and lifestyle
variables were similar within each region (data not shown).
Finally, concentrations of vitamin B12 were lower, whereas
concentrations of vitamins B2, B6, and tHcy were higher
among those with fasting blood samples.
Patterns of B-vitamins, amino acids and related nutrients
in Europe
We investigated patterns across three European regions (North:
Sweden and Denmark; Central: France, United Kingdom, the
Netherlands and Germany; South: Italy, Spain and Greece).
Sex-specific standardised median (5th–95th percentile)
concentrations (Table 3) showed that folate concentrations
were lowest in Northern Europe in both men (10·4
(4·82–24·2) nmol/l) and women (10·7 (4·73–31·5) nmol/l) and
highest concentrations were seen in Central Europe
in both men (14·6 (6·40–41·8) nmol/l) and women (13·9
(6·05–44·8) nmol/l). However, the geographic pattern in tHcy
concentrations – an inverse marker of folate and vitamin B12
status – did not mirror patterns of folate concentrations, and
tHcy concentrations were lowest in Northern Europe.
Vitamin B12 status was generally better in Northern Europe
among men and women, as reflected by higher vitamin B12
and lower MMA concentrations, but did not show a clear
north–south gradient. Highest vitamin B2 concentrations were
observed in men (22·2 (11·1–85·0) nmol/l) and women
(26·0 (12·5–69·5) nmol/l) in the North, with decreasing concen-
trations from the north to south (Ptrend , 0·001 in both sexes).
Likewise, we observed that vitamin B6 concentrations
were highest in Northern European women (74·4
(33·8–528) nmol/l) and decreased from the north to south
(Ptrend , 0·001), whereas vitamin B6 concentrations in men
were highest in Central Europe (77·3 (41·8–207) nmol/l)
(Table 3). In men, standardised median concentrations of the
amino acids sarcosine, serine and glycine were lowest in
Northern Europe, and showed increasing concentrations
towards Southern Europe (Ptrend , 0·01 for all). No such clear
patterns in amino acid concentrations were observed in
women. Furthermore, Southern European men had the highest
concentrations of the nutrients choline and betaine, with a
significant north–south gradient for both nutrients, whereas
these patterns were not observed for women (Table 3). After
further adjustment for season of blood collection, smoking
and alcohol intake, the standardised medians remained essen-
tially the same (data not shown).
We also compared relative differences in B-vitamin concen-
trations between regions at the 0·025, 0·05, 0·1, 0·25, 0·5, 0·75,
0·9, 0·95 and 0·975 percentiles of the B-vitamin distributions
(Fig. 1). Relative to Southern Europe, folate concentrations
in Central and the Northern Europe showed a shift to higher
levels of the upper part of the distribution (for Central
Europe) and a shift to lower levels of the lower part of the
distribution (for Northern Europe). Differences in tHcy
Table 1. Characteristics of the study population
Region*
Total population North Central South P for difference
n 5446 1222 2499 1725
Sex
Female (%) 46·1 45·5 50·4 40·9 ,0·001†
Age (years)
Mean 59·0 59·7 60·5 57·1 ,0·001‡
Range 28·5–78·6 30·0–73·3 34·5–73·3 28·5–78·6
Smoking (%)
Unknown 1·3 0·6 1·1 2·0
Never 42·4 38·8 43·1 44·2
Ex 34·3 31·8 39·4 28·6
Current 22·0 28·9 16·4 25·2 ,0·001†
Alcohol consumption (g/d)§
Abstainers: 0 g/d (%) 14·3 9·7 12·7 19·8
$ 0·1 g/d , 4·9 (%) 28·5 29·7 32·3 22·1
$ 4·9 g/d , 30 (%) 41·8 46·9 43·5 35·9
$ 30 g/d (%) 15·4 13·7 11·5 22·2 ,0·001†
MTHFR 677 C! T§
CC (%) 41·8 47·8 44·3 34·3
CT (%) 45·0 44·0 43·5 47·8
TT (%) 13·2 8·2 12·2 17·9 ,0·001†
MTHFR, methylenetetrahydrofolate reductase.
* North: Sweden and Denmark; Central: France, United Kingdom, the Netherlands and Germany; South: Italy, Spain and Greece.
†P for difference by x 2 test.
‡P for difference by ANOVA.
§ Data on alcohol intake and MTHFR 677C!T genotype data were available for 99·6 % (twenty-two missing) and 87·8 % (664 miss-
ing), respectively.
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Table 2. Plasma concentrations of vitamins B2, B6, B12 and folate by demography, lifestyle and methylenetetrahydrofolate reductase (MTHFR)* genotype
(Medians and 5th–95th percentiles)
Folate (nmol/l) Vitamin B12 (pmol/l) Vitamin B2 (nmol/l)† Vitamin B6 (nmol/l)‡ tHcy (mmol/l)
Median 5th–95th percentiles Median 5th–95th percentiles Median 5th–95th percentiles Median 5th–95th percentiles Median 5th–95th percentiles
Sex
Male (n 2889) 12·6 5·44–34·5 297 161–523 18·9 9·03–70·2 70·7 34·7–175 11·1 7·04–19·1
Female (n 2557) 12·7 5·66–38·6 324 174–589 21·6 10·1–76·3 64·3 31·4–265 9·56 6·16–16·0
P for difference§ 0·046 ,0·001 ,0·001 ,0·001 ,0·001
Age (years)
, 60 (n 3005) 12·2 5·58–33·3 316 175–563 19·8 9·39–72·3 66·8 33·2–199 9·80 6·28–16·7
. 60 (n 2441) 13·0 5·61–39·1 298 157–550 20·7 9·54–76·1 68·6 33·0–213 11·1 7·0–18·8
P for difference§ ,0·001 ,0·001 0·014 0·126 ,0·001
Smoking
Never (n 2313) 13·2 5·98–38·4 314 169–589 21·2 10·1–76·8 68·4 35·0–222 10·1 6·32–16·5
Ex (n 1867) 13·0 6·01–37·4 305 162–533 20·8 9·41–85·4 72·8 36·2–205 10·7 6·75–17·5
Current (n 1196) 10·7 4·66–30·7 304 160–539 17·8 8·49–57·2 59·4 27·6–199 10·7 6·56–20·5
P for trendk ,0·001 0·002 ,0·001 ,0·001 ,0·001
Alcohol{
Abstainer (n 774) 13·3 5·65–39·0 315 160–614 20·3 9·71–72·3 62·0 30·0–201 10·5 6·71–18·8
0·1–4·9 g/d (n 1544) 12·1 5·31–37·1 318 168–563 21·0 9·82–65·4 61·9 31·4–203 10·2 6·35–17·2
4·9–30 g/d (n 2271) 12·7 5·66–34·7 304 165–549 20·5 9·41–76·1 70·6 34·6–219 10·3 6·54–17·2
$ 30g/d (n 835) 12·4 5·89–35·5 300 164–518 19·0 8·42–92·5 76·5 38·0–196 10·8 6·65–19·5
P for trendk 0·005 ,0·001 0·021 ,0·001 ,0·001
MTHFR 677*{
CC (n 1999) 13·0 5·93–36·3 304 167–530 19·8 9·51–68·9 67·6 33·3–208 10·4 6·42–17·0
CT (n 2152) 12·5 5·59–34·2 306 162–573 19·8 9·19–65·9 67·0 32·5–207 10·4 6·59–17·3
TT (n 631) 11·0 5·02–37·2 298 163–536 19·2 8·49–89·8 70·4 32·7–200 11·5 6·98–23·9
P for trendk ,0·001 0·475 0·764 0·278 ,0·001
Prandial status
Fasting (n 2333) 12·8 5·63–37·6 295 160–528 20·8 9·78–75·7 71·5 33·5–240 10·7 6·67–19·5
Non-fasting (n 2572) 13·1 5·74–36·4 316 167–587 19·1 8·94–66·5 64·2 32·4–178 10·3 6·32–18·5
Unknown (n 541) 11·0 5·05–40·4 314 177–549 24·2 12·3–101 74·8 37·8–267 10·8 6·91–18·0
P for difference§ 0·059 ,0·001 ,0·001 ,0·001 ,0·001
tHcy, total homocysteine.
* Not measured in controls belonging to the pancreatic cancer study.
† Vitamin B2: riboflavin þ FMN.
‡ Vitamin B6: pyridoxal-5
0-phosphate þ pyridoxal þ 4-pyridoxic acid.
§P for difference by Mann–Whitney U, unknown prandial status excluded from statistical test.
kP for trend by Wald test.
{Data on alcohol intake and MTHFR 677C!T genotype data were available for 99·6 % (twenty-two missing) and 87·8 % (664 missing), respectively.
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Table 3. Standardised plasma concentrations and trends across European regions* of B-vitamins and related metabolites
(Medians and 5th–95th percentiles)
Standardised median plasma concentrations
Men Women
All men (n 2889) North (n 666) Central (n 1204) South (n 1019) All (n 2557) North (n 556) Central (n 1295) South (n 706)
Median
5th–95th
percentiles Median
5th–95th
percentiles Median
5th–95th
percentiles Median
5th–95th
percentiles Ptrend† Median
5th–95th
percentiles Median
5th–95th
percentiles Median
5th–95th
percentiles Median
5th–95th
percentiles Ptrend†
Vitamins
Folate
(nmol/l)
12·7 5·63–34·8 10·4 4·82–24·2 14·6 6·40–41·8 12·3 5·45–30·8 ,0·001 13·0 5·72–39·0 10·7 4·73–31·5 13·9 6·05–44·8 13·7 6·29–34·1 ,0·001
B12 (pmol/l) 298 164–509 330 198–564 286 157–462 290 156–544 ,0·001 326 177–571 352 186–595 311 173–559 330 182–583 0·037
B2 (nmol/l)‡ 19·1 9·59–71·2 22·2 11·1–85·0 20·5 10·5–76·8 14·6 7·62–47·4 ,0·001 21·8 10·9–76·5 26·0 12·5–69·5 23·0 12·2–77·9 17·2 8·11–84·2 ,0·001
B6 (nmol/l)§ 71·2 36·7–180 75·1 36·5–209 77·3 41·8–207 61·6 32·2–134 ,0·001 65·6 33·7–292 74·4 33·8–528 67·8 36·8–320 55·1 28·8–111 ,0·001
Amino acids
(mmol/l)
tHcy 11·1 7·73–19·4 10·3 7·32–16·8 11·4 7·91–20·2 11·4 7·82–20·1 ,0·001 9·66 6·51–17·3 8·85 6·06–14·7 10·4 7·02–18·6 9·09 6·27–15·0 0·853
Cys 273 228–328 278 232–337 272 227–324 270 227–321 0·001 262 219–322 269 225–327 260 218–320 258 214–316 ,0·001
Met 26·6 18·2–39·6 25·9 17·7–38·4 25·1 17·5–38·6 28·7 20·8–41·9 ,0·001 23·9 17·0–36·3 23·0 16·7–35·0 23·4 16·1–36·7 25·6 19·1–36·6 ,0·001
Serk 133 91·4–188 123 85·5–176 125 88·5–183 142 104–194 ,0·001 143 95·8–206 129 88·5–183 147 97·9–211 143 98·3–209 0·003
Glyk 256 182–371 234 177–367 251 174–377 263 198–370 ,0·001 293 190–507 275 174–496 301 195–521 285 194–486 0·965
Sark 1·60 0·98–2·89 1·44 0·96–2·57 1·53 0·98–2·90 1·71 1·00–2·94 ,0·001 1·34 0·81–2·47 1·31 0·81–2·11 1·29 0·78–2·33 1·46 0·94–2·89 0·022
Nutrients or
intermedi-
ates (mmol/l)
MMA 0·18 0·12–0·36 0·17 0·11–0·34 0·18 0·12–0·39 0·17 0·11–0·33 0·999 0·17 0·11–0·33 0·17 0·11–0·28 0·18 0·12–0·36 0·17 0·11–0·31 0·999
Choline{ 9·76 6·57–15·1 9·04 6·27–13·5 9·82 6·46–15·6 10·5 7·28–16·3 ,0·001 9·17 6·19–14·5 8·65 5·45–12·5 9·37 6·29–15·1 9·26 6·54–15·1 0·038
Betaine{ 35·9 23·1–58·2 34·9 23·1–57·7 35·5 22·9–56·9 38·3 23·1–61·6 ,0·001 29·2 16·8–48·1 29·0 16·7–46·4 28·1 16·8–46·7 31·9 16·7–51·1 0·007
DMG{ 3·72 2·45–6·05 3·67 2·33–5·64 3·68 2·42–5·96 3·86 2·61–6·49 0·012 3·24 2·10–5·42 3·21 2·17–5·39 3·26 2·09–5·21 3·28 1·96–5·88 0·478
Cystathionine 0·18 0·09–0·46 0·20 0·10–0·63 0·18 0·10–0·43 0·17 0·09–0·39 ,0·001 0·16 0·08–0·42 0·17 0·08–0·51 0·16 0·08–0·42 0·16 0·09–0·36 0·048
tHcy, total homocysteine; MMA, methylmalonic acid; DMG, dimethylglycine.
* North: Sweden and Denmark; Central: France, United Kingdom, the Netherlands and Germany; South: Italy, Spain and Greece.
† By Quantile regression, Wald test.
‡ Vitamin B2: riboflavin þ FMN not measured in controls matched to lung cancer.
§ Vitamin B6: pyridoxal-5
0-phosphate þ pyridoxal þ 4-pyridoxic acid.
kNot measured in controls matched to gastric and colorectal cancer.
{Not measured in controls matched to lung and pancreas cancer.
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concentrations were small. The profiles for markers of vitamin
B12 status were complementary to each other, with the lowest
vitamin B12 and highest MMA concentrations in Central
Europe. The relative regional differences in vitamin B2 con-
centrations over the whole distribution range were symmetri-
cal with higher levels for Central and the Northern Europe.
There were regional differences in vitamin B6 concentrations,
with highest levels in Central and the Northern Europe.
The distribution curve was asymmetrical and showed most
pronounced differences at higher concentrations.
Analyses of the proportion of individuals with deficient
B-vitamin status, as based on the 2·5th percentile distribution
of the total study population, revealed that deficiencies of vita-
min B2 (6·2 % with concentrations ,7·9 nmol/l) and vitamin
B6 (4·5 % with concentrations ,28·9 nmol/l) were most
prevalent in Southern European countries, whereas vitamin
B12 and folate deficiency were more frequently observed in
Central (2·9 % with concentrations ,140 pmol/l) and Northern
Europe (4·6 % with concentrations ,4·6 nmol/l), respectively
(data not shown).
Distribution of folate according to
methylenetetrahydrofolate reductase 677C! T genotype
There was an increasing north–south gradient for the number
of T-alleles of the MTHFR 677C! T genotype (Table 1).
We investigated the distribution of folate and tHcy according
to the MTHFR 677C! T genotype across regions by quantile
regression (Table 4 and Fig. S1, available online). In the total
study population and in each region, there was a trend
towards lower folate and higher tHcy concentrations
according to the number of T-alleles (Table 4). Further, the
distribution was asymmetric, with the largest differences in
the lower quantiles of folate and the highest quantiles in
tHcy. The asymmetric profile and differences were most
pronounced in Southern Europe (Fig. S1, available online).
Thus, the MTHFR 677TT genotype was associated with an
increased prevalence of subjects with low folate and high
tHcy, suggesting impaired folate status, and exerted the largest
differences on distribution of these indices in populations with
the highest MTHFR 677 T allele frequency.
Table 4. Plasma folate and total homocysteine (tHcy) concentrations according to the methylenetetrahydrofolate reductase (MTHFR) 677C! T geno-
type across European regions*
(Medians and 5th–95th percentiles)
North (n 1221) Central (n 1221) South (n 935)
MTHFR 677 Median 5th–95th percentiles Median 5th–95th percentiles Median 5th–95th percentiles P for difference†
Plasma folate concentrations
CC 9·93 4·78–31·9 13·1 6·23–39·4 13·5 6·10–31·2
CT 10·0 4·24–26·5 12·6 5·95–36·5 12·6 5·66–28·4
TT 9·02 4·09–23·5 11·4 4·96–45·7 10·4 4·64–26·3 ,0·0001
Plasma tHcy concentrations
CC 9·65 6·23–16·8 9·75 6·57–15·6 9·16 5·92–14·8
CT 9·76 6·51–18·0 10·0 6·75–15·6 8·85 6·05–15·4
TT 10·6 6·62–20·4 10·7 6·73–21·0 9·82 6·21–23·7 ,0·0001
* North: Sweden and Denmark; Central: France, United Kingdom, the Netherlands and Germany; South: Italy, Spain and Greece.
†P for difference by Kruskal–Wallis test.
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Fig. 1. Plasma concentrations of B-vitamins across Western European regions by quantile regression. Concentrations of the vitamins and their markers are
shown on the x-axis, and the differences between the European regions are shown on the y-axis. The 0·025, 0·05, 0·1, 0·25, 0·5, 0·75, 0·9, 0·95 and 0·975 per-
centiles are reflected by the dots. The model is adjusted for age, sex and sub-study and prandial status. Southern Europe is the reference category. tHcy, total
homocysteine; MMA, methylmalonic acid. , South (reference); , Central; , North.
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Discussion
Principal findings
The present study is the largest to date to investigate
geographical patterns in blood concentrations of B-vitamins,
amino acids and other metabolites related to one-carbon
metabolism. Folate concentrations were lowest in Northern
European countries, with increasing concentrations from
north to south in women. Vitamins B2 and B6 concentrations
were highest in Northern European countries and showed a
clear decreasing north–south gradient in both men and
women. Concentrations of tHcy, sarcosine, serine and glycine
in men were lowest in Northern Europe, and increased
towards Southern Europe. The highest concentrations of the
nutrients choline and betaine were observed in Southern
Europe, but there was no significant north–south gradient
for choline in men.
B-vitamin status
Food patterns, traditions of vitamin supplementation and life-
style factors differ greatly across European regions. Compared
with the overall EPIC study population, the dietary pattern of
Italy and Greece is characterised by a higher consumption of
plant foods – the main source of folate – and a lower con-
sumption of animal – the main source of vitamin B12 – and
processed foods. Diets in France and Spain contain relatively
high amounts of plant foods and animal products, whereas
the UK general population has a relatively high consumption
of tea, sauces, cakes, soft drinks, margarine and butter. Finally,
the diet in the Nordic countries, The Netherlands, Germany
and the UK general population is relatively high in potatoes
and animal, processed and sweetened/refined foods(44,45).
A lower intake of fruits and vegetables in Northern Europe
may explain the tendency towards lower folate concentrations
in the Northern region, and is in line with the previously
reported lower folate intake(20,23) and plasma levels(21) in
Northern countries. The higher plasma vitamin B12 concen-
trations in Northern Europe agree with higher vitamin B12
intake in Northern countries(46) and probably reflect a
higher meat intake in this region(44). Lower vitamin B2 concen-
trations observed in Southern countries could be partially
explained by a lower consumption of dairy products(47).
These findings are in line with results from the SENECA
study showing a higher consumption of dairy products in
Northern countries compared with Southern countries(48),
although the EPIC population had higher dairy intakes in
Southern countries(47), as well as higher intakes of vegetables,
fruits and cereals, which are also sources of vitamin B2.
(49)
Vitamin B6 concentrations were lower in Southern countries
compared with Northern countries, and differences between
regions became larger at the higher end of the vitamin B6 dis-
tribution, where the concentrations are similar to concen-
trations obtained by vitamin B6 supplements
(50,51).
A subsample of the EPIC population revealed a
north–south gradient in vitamin supplement use, with higher
consumption in Northern European countries than in Southern
European countries, and higher consumption for women than
for men(52), which could also partially explain the higher con-
centrations observed for vitamins B2, B6 and B12, but not for
folate in the Northern region.
Mandatory folic acid fortification has not been implemented
in Western European countries. However, national policies on
voluntary folic acid fortification vary considerably(53), which
may also affect folate status in individuals who do not use sup-
plements(54). In addition to higher folate status, mandatory(55)
or voluntary food folic acid fortification(54) also influences the
concentrations of other B-vitamins, tHcy and nutrients
involved in one-carbon metabolism(3). However, it is unclear
to what extent any voluntary fortification might have affected
the between-region differences in the present study.
One study observed a lower folate intake in Southern Euro-
pean countries in the summer compared with Northern
countries(23). This may be explained by the fact that green
leafy vegetables, one of the major dietary sources of folate
in those countries, are broadly known as an early-spring or
late autumn crop(23). Adjustment for season of blood collec-
tion did not affect the trends observed in the present study.
Smoking behaviour(11) and alcohol consumption(13) are
known lifestyle factors that affect B-vitamin status. Even
though there were differences in smoking behaviour and alco-
hol consumption across regions, additional adjustment for
these lifestyle factors did not materially alter the estimated pat-
terns across regions.
Amino acids and other nutrients
Folate-dependent one-carbon metabolism is closely linked to
pathways involving amino acids like homocysteine, methion-
ine, serine and glycine, and donors of one-carbon units such
as choline, betaine and related methylamines(3). Therefore, it
is important to consider not only B-vitamins, but also amino
acids, and other nutrients and metabolites in epidemiological
studies on one-carbon metabolism. Patterns of plasma con-
centrations of the amino acids tHcy, methionine, sarcosine,
serine and glycine were consistent, with the lowest concen-
trations in Northern Europe and increasing concentrations
towards Southern Europe in men. Likewise, men in Southern
Europe had the highest concentrations of the nutrients choline
and betaine, whereas in women, betaine and choline concen-
trations were highest in Southern and the Central Europe,
respectively. The high choline concentrations are likely to
be attributed to high egg consumption(56), which has been
reported to be highest in Spain(57).
Methylenetetrahydrofolate reductase 677C! T
genotype and folate status
Prevalence of the MTHFR 677TT genotype in white populations
in Europe, North America and Australia varies from 8 to 20 %,
and a trend of increasing frequency of the TT genotype has
been observed from north to south Europe(58), which agrees
with the present study. The TT variant, which was most preva-
lent in Southern Europe, was associated with lower folate and
higher tHcy concentrations, as has previously been shown(59).
Folate and tHcy are the metabolites that are most strongly
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influenced by MTHFR genotype(10). Although one would
thereby expect lower folate status in the South as well, we
observed that folate concentrations were higher in the South,
suggesting that dietary factors are stronger determinants for
folate status than this specific genetic factor.
Limitations and strengths
The EPIC study investigates the relation of diet and lifestyle
with cancer incidence, and was as such not designed to be
representative of the general European population. The
study cohort comprised individuals recruited from the general
population, blood donors (Spain and Italy), teachers and
school workers (France), a health-conscious population
(UK) and women participating in a breast cancer screening
programme (The Netherlands and Italy)(23). The present
study population may therefore reflect a more health-con-
scious part of the European population. The patterns observed
may consequently have been under- or overestimated as a
result of potential selection bias. An important strength of
the present study is the large sample size of individuals
recruited from several Western European countries. Neverthe-
less, the present study cannot provide any estimates of poten-
tial differences in disease risk profiles across the European
regions as we lack data on disease status or use of medication
that may affect metabolite concentrations. Furthermore, the
impact of alcohol consumption on the observed patterns
could not be investigated in further detail as we did not
have data specifically on the consumption of beer, wine or
spirits. Finally, it is known that menopausal status affects
choline concentrations(60). However, the present study
lacked statistical power to investigate whether postmenopau-
sal status affected choline concentrations across the European
regions.
A standardised protocol for the collection and storage of
blood was used in the majority of participating study centres;
all blood samples were collected in citrate plasma and all bio-
chemical analyses were performed in one laboratory. This
reduced pre-analytical variability due to differences in
sample handling and eliminated inter-assay variations.
Recently, the same laboratory investigated the stability of
metabolites related to one-carbon metabolism at room tem-
perature and during long-term storage(26). The results of that
study underscore the importance of adequate sample handling
and storage in epidemiological and clinical studies(26). Folate,
species of vitamins B2 and B6 and choline appear to be
unstable during storage(26). However, the sum of riboflavin
and FMN and the sum of pyridoxal-50-phosphate, PL and
4-pyridoxic acid are stable, and we therefore presented the
sum of these species as measures of vitamins B2 and B6
status in the present investigation. In addition, concentrations
of choline, but not betaine, increase with increasing storage
time(26). Therefore, higher concentrations of both choline
and betaine observed in Central European countries are
more likely explained by a higher dietary intake of choline
than by pre-analytical errors. The observed correlations
between metabolites were essentially the same when
calculated within countries, regions or the total study popu-
lation, observations that support data integrity.
Conclusions
The present study covers a large geographical area in Europe,
and presents a comprehensive spectrum of B-vitamins, amino
acids and other nutrients involved in one-carbon metabolism.
The study reveals clear decreasing north–south gradients of
vitamins B2 and B6, and increasing gradients of folate and
the majority of amino acids included in the present study.
These differences may reflect distinct dietary and lifestyle
patterns between regions, and may be relevant for the study
of regional differences in chronic disease incidence in
Western Europe.
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